Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods

Mushtaq, Shazad, Warner, Marina, Johnson, Alan P and Livermore, David M (2004) Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. Journal of Antimicrobial Chemotherapy, 54 (3). pp. 617-20. ISSN 0305-7453

Full text not available from this repository. (Request a copy)

Abstract

Dalbavancin is a long-half-life (9-12 days) glycopeptide, now in Phase 3 development. Its pharmacokinetics may facilitate home intravenous therapy, early discharge and long prophylaxis.

Item Type: Article
Uncontrolled Keywords: anti-bacterial agents,culture media,drug resistance, multiple, bacterial,glycopeptides,microbial sensitivity tests,staphylococcus,streptococcus,teicoplanin
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Jan 2014 15:04
Last Modified: 21 Apr 2020 22:38
URI: https://ueaeprints.uea.ac.uk/id/eprint/46736
DOI: 10.1093/jac/dkh401

Actions (login required)

View Item View Item